VX-210

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-210, covering 2020-01-22 to 2020-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury [Phase 2, Phase 3]

See pricing